Adaptimmune Therapeutics plc (ADAP) is down -0.11% from 52 weeks low but Don’t Get Your Hopes high
Adaptimmune Therapeutics plc (NASDAQ:ADAP) shares fell to a low of $3.88 before closing at $3.90. Intraday shares traded counted 1.09 million, which was -16.77% lower